Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.95
-0.03 (-0.43%)
At close: Jul 1, 2025, 4:00 PM
6.99
+0.04 (0.58%)
After-hours: Jul 1, 2025, 4:00 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $152.81 million as of July 1, 2025. Its market cap has increased by 344.21% in one year.
Market Cap
152.81M
Enterprise Value
165.17M
1-Year Change
344.21%
Ranking
Category
Stock Price
$6.95
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $152.81M, an increase of 142.14%. That is a compound annual growth rate of 16.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |